Navin Fluorine International Limited has announced the commencement of commercial production at Phase 1 of its cGMP-4 plant located in Dewas. This significant development follows the successful validation of batches by their European partner. The company had previously intimated about this project on February 06, 2024, and September 04, 2025. The commencement of operations at this new facility marks a key milestone in the company's expansion and operational growth. This intimation is made in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is also available on the company's website, www.nfil.in.
